Research output per year
Research output per year
- 1 - 50 out of 53 results
Search results
-
2023
A comprehensive assessment of cell type-specific differential expression methods in bulk data
Meng, G., Tang, W., Huang, E., Li, Z. & Feng, H., Jan 1 2023, In: Briefings in Bioinformatics. 24, 1, bbac516.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Immune Checkpoint Inhibitors in pMMR/MSS Colorectal Cancer
El Hajj, J., Reddy, S., Verma, N., Huang, E. H. & Kazmi, S. M., Dec 2023, In: Journal of Gastrointestinal Cancer. 54, 4, p. 1017-1030 14 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
Dilliard, S. A. & Siegwart, D. J., Apr 2023, In: Nature Reviews Materials. 8, 4, p. 282-300 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access87 Scopus citations -
2021
COVID-19 Communication from Seven Health Care Institutions in North Texas for English- And Spanish-Speaking Cancer Patients: Mixed Method Website Study
Higashi, R. T., Sweetenham, J. W., Israel, A. D. & Tiro, J. A., Jul 2021, In: JMIR Cancer. 7, 3, e30492.Research output: Contribution to journal › Review article › peer-review
Open Access7 Scopus citations -
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors
Servetto, A., Formisano, L. & Arteaga, C. L., Dec 2021, In: Biochimica et Biophysica Acta - Reviews on Cancer. 1876, 2, 188595.Research output: Contribution to journal › Review article › peer-review
Open Access15 Scopus citations -
Prioritization of novel agents for patients with rhabdomyosarcoma: A report from the children’s oncology group (cog) new agents for rhabdomyosarcoma task force
Pacenta, H. L., Allen-Rhoades, W., Langenau, D., Houghton, P. J., Keller, C., Heske, C. M., Deel, M. D., Linardic, C. M., Shern, J. F., Stewart, E., Turpin, B., Harrison, D. J., Khan, J., Mascarenhas, L., Skapek, S. X., Meyer, W. H., Hawkins, D. S., Chen, E. Y., Amatruda, J. F., Hingorani, P., & 1 others, Apr 1 2021, In: Journal of Clinical Medicine. 10, 7, 1416.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations -
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
Sparber-Sauer, M., Orbach, D., Navid, F., Hettmer, S., Skapek, S., Corradini, N., Casanova, M., Weiss, A., Schwab, M. & Ferrari, A., May 11 2021, In: British journal of cancer. 124, 10, p. 1637-1646 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access11 Scopus citations -
Recent advances in the targeted fluorescent probes for the detection of metastatic bone cancer
Wu, P., Siegwart, D. J. & Xiong, H., Aug 2021, In: Science China Chemistry. 64, 8, p. 1283-1296 14 p.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations -
The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis
Chandra, R., Karalis, J. D., Liu, C., Murimwa, G. Z., Park, J. V., Heid, C. A., Reznik, S. I., Huang, E., Minna, J. D. & Brekken, R. A., Dec 1 2021, In: Cancers. 13, 24, 6206.Research output: Contribution to journal › Review article › peer-review
Open Access53 Scopus citations -
2020
Overcoming Endocrine Resistance in Breast Cancer
Hanker, A. B., Sudhan, D. R. & Arteaga, C. L., Apr 13 2020, In: Cancer Cell. 37, 4, p. 496-513 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access383 Scopus citations -
2019
A Surgeon’s Guide to Treating Older Patients With Colorectal Cancer
Kim, S., Lee, S. C., Skinner, C. S., Brown, C. J. & Balentine, C. J., Feb 15 2019, In: Current Colorectal Cancer Reports. 15, 1Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Erratum: Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence (Science Translational Medicine (2019) 11, 476, (eaaw6162), 10.1126/scitranslmed.aaw6162)
Balko, J. M., Schwarz, L. J., Luo, N., Estrada, M. V., Giltnane, J. M., Dávila-González, D., Wang, K., Sánchez, V., Dean, P. T., Combs, S. E., Hicks, D., Pinto, J. A., Landis, M. D., Doimi, F. D., Yelensky, R., Miller, V. A., Stephens, P. J., Rimm, D. L., Gómez, H., Chang, J. C., & 3 others, Jan 23 2019, In: Science translational medicine. 11, 476, eaaw6162.Research output: Contribution to journal › Review article › peer-review
-
Rhabdomyosarcoma
Skapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E., Shipley, J., Barr, F. G. & Hawkins, D. S., Dec 1 2019, In: Nature Reviews Disease Primers. 5, 1, 1.Research output: Contribution to journal › Review article › peer-review
357 Scopus citations -
Strategies, design, and chemistry in siRNA delivery systems
Dong, Y., Siegwart, D. J. & Anderson, D. G., Apr 2019, In: Advanced Drug Delivery Reviews. 144, p. 133-147 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access328 Scopus citations -
2017
Evaluation of effectiveness of survivorship programmes: how to measure success?
Halpern, M. T. & Argenbright, K. E., Jan 1 2017, In: The Lancet Oncology. 18, 1, p. e51-e59Research output: Contribution to journal › Review article › peer-review
37 Scopus citations -
Neoadjuvant trials in ER+ breast cancer: A tool for acceleration of drug development and discovery
Guerrero-Zotano, A. L. & Arteaga, C. L., 2017, In: Cancer discovery. 7, 6, p. 561-574 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access27 Scopus citations -
2015
Cardio-oncology: How new targeted cancer therapies and precision medicine can inform cardiovascular discovery
Bellinger, A. M., Arteaga, C. L., Force, T., Humphreys, B. D., Demetri, G. D., Druker, B. J. & Moslehi, J. J., Dec 8 2015, In: Circulation. 132, 23, p. 2248-2258 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access93 Scopus citations -
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee molecular profiling surveys
Kurzrock, R., Colevas, A. D., Olszanski, A., Akerley, W., Arteaga, C. L., Carson, W. E., Clark, J. W., DiPersio, J. F., Ettinger, D. S., Morgan, R. J., Schwartzberg, L. S., Venook, A. P., Gocke, C. D., Tait, J. & Stewart, F. M., Nov 1 2015, In: JNCCN Journal of the National Comprehensive Cancer Network. 13, 11, p. 1337-1346 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access18 Scopus citations -
Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics
Abramson, R. G., McGhee, C. R., Lakomkin, N. & Arteaga, C. L., Jun 1 2015, In: Academic radiology. 22, 6, p. 779-786 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access28 Scopus citations -
2014
ERBB receptors: From oncogene discovery to basic science to mechanism-based cancer therapeutics
Arteaga, C. L. & Engelman, J. A., Mar 17 2014, In: Cancer Cell. 25, 3, p. 282-303 22 p.Research output: Contribution to journal › Review article › peer-review
Open Access760 Scopus citations -
Models of cancer survivorship health care: moving forward
Oeffinger, K. C., Argenbright, K. E., Levitt, G. A., McCabe, M. S., Anderson, P. R., Berry, E., Maher, J., Merrill, J. & Wollins, D. S., 2014, In: American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. p. 205-213 9 p.Research output: Contribution to journal › Review article › peer-review
38 Scopus citations -
2013
Optimal targeting of HER2-PI3K signaling in breast cancer: Mechanistic insights and clinical implications
Rexer, B. N. & Arteaga, C. L., Jul 1 2013, In: Cancer research. 73, 13, p. 3817-3820 4 p.Research output: Contribution to journal › Review article › peer-review
Open Access48 Scopus citations -
Progress in breast cancer: Overview
Arteaga, C. L., Dec 1 2013, In: Clinical Cancer Research. 19, 23, p. 6353-6359 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access9 Scopus citations -
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer
Ciruelos, E., Cortes-Funes, H., Ghanem, I., Manso, L. & Arteaga, C., Sep 1 2013, In: Anti-Cancer Drugs. 24, 8, p. 769-780 12 p.Research output: Contribution to journal › Review article › peer-review
11 Scopus citations -
The genomic map of breast cancer: Which roads lead to better targeted therapies?
Balko, J. M., Stricker, T. P. & Arteaga, C. L., Jul 31 2013, In: Breast Cancer Research. 15, 4, 209.Research output: Contribution to journal › Review article › peer-review
Open Access10 Scopus citations -
2012
Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.
Rexer, B. N. & Arteaga, C. L., 2012, In: Critical reviews in oncogenesis. 17, 1, p. 1-16 16 p.Research output: Contribution to journal › Review article › peer-review
Open Access269 Scopus citations -
Molecular signatures of lung cancer: Defining new diagnostic and therapeutic paradigms
Balko, J. M. & Arteaga, C. L., Mar 2 2012, In: Molecular Diagnosis and Therapy. 16, 1, p. 1-6 6 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Treatment of HER2-positive breast cancer: Current status and future perspectives
Arteaga, C. L., Sliwkowski, M. X., Osborne, C. K., Perez, E. A., Puglisi, F. & Gianni, L., Jan 2012, In: Nature Reviews Clinical Oncology. 9, 1, p. 16-32 17 p.Research output: Contribution to journal › Review article › peer-review
704 Scopus citations -
2011
Mutations in the phosphatidylinositol 3-kinase pathway: Role in tumor progression and therapeutic implications in breast cancer
Miller, T. W., Rexer, B. N., Garrett, J. T. & Arteaga, C. L., Nov 1 2011, In: Breast Cancer Research. 13, 6, 224.Research output: Contribution to journal › Review article › peer-review
Open Access350 Scopus citations -
New strategies in HER2-overexpressing breast cancer: Many combinations of targeted drugs available
Abramson, V. & Arteaga, C. L., Mar 1 2011, In: Clinical Cancer Research. 17, 5, p. 952-958 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access57 Scopus citations -
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer
Miller, T. W., Balko, J. M. & Arteaga, C. L., Nov 20 2011, In: Journal of Clinical Oncology. 29, 33, p. 4452-4461 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access332 Scopus citations -
Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: Mechanisms and clinical implications
Garrett, J. T. & Arteaga, C. L., May 1 2011, In: Cancer Biology and Therapy. 11, 9, p. 793-800 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access151 Scopus citations -
When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene
Chow, A., Arteaga, C. L. & Wang, S. E., Jun 2011, In: Journal of mammary gland biology and neoplasia. 16, 2, p. 81-88 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access47 Scopus citations -
2009
Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists
Rexer, B. N., Engelman, J. A. & Arteaga, C. L., Jan 1 2009, In: Cell Cycle. 8, 1, p. 18-22 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access67 Scopus citations -
2006
Inhibition of TGFβ signaling in cancer therapy
Arteaga, C. L., Feb 2006, In: Current Opinion in Genetics and Development. 16, 1, p. 30-37 8 p.Research output: Contribution to journal › Review article › peer-review
109 Scopus citations -
Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy.
Biswas, S., Criswell, T. L., Wang, S. E. & Arteaga, C. L., Jul 15 2006, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 12, 14 Pt 1, p. 4142-4146 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access66 Scopus citations -
2005
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
Baselga, J. & Arteaga, C. L., 2005, In: Journal of Clinical Oncology. 23, 11, p. 2445-2459 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access675 Scopus citations -
2004
Modeling the cancer patient with genetically engineered mice: Prediction of toxicity from molecule-targeted therapies
Roberts, R. B., Arteaga, C. L. & Threadgill, D. W., Feb 2004, In: Cancer Cell. 5, 2, p. 115-120 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access43 Scopus citations -
2003
ErbB-targeted therapeutic approaches in human cancer
Arteaga, C. L., Mar 10 2003, In: Experimental Cell Research. 284, 1, p. 122-130 9 p.Research output: Contribution to journal › Review article › peer-review
208 Scopus citations -
Inhibiting tyrosine kinases: successes and limitations.
Arteaga, C. L., 2003, In: Cancer biology & therapy. 2, 4 Suppl 1, p. S79-83Research output: Contribution to journal › Review article › peer-review
Open Access24 Scopus citations -
Targeting the TGFβ signaling network in human neoplasia
Dumont, N. & Arteaga, C. L., Jun 1 2003, In: Cancer Cell. 3, 6, p. 531-536 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access213 Scopus citations -
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
Arteaga, C. L., 2003, In: Breast Cancer Research. 5, 2, p. 96-100 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access56 Scopus citations -
2002
Epidermal growth factor receptor dependence in human tumors: More than just expression?
Arteaga, C. L., 2002, In: Oncologist. 7, SUPPL. 4, p. 31-39 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access414 Scopus citations -
The tumor microenvironment: A potential arbitrator of the tumor suppressive and promoting actions of TGFβ
Dumont, N. & Arteaga, C. L., Dec 2002, In: Differentiation. 70, 9-10, p. 574-582 9 p.Research output: Contribution to journal › Review article › peer-review
34 Scopus citations -
2001
Tyrosine kinase inhibitors-ZD1839 (Iressa)
Arteaga, C. L. & Johnson, D. H., 2001, In: Current Opinion in Oncology. 13, 6, p. 491-498 8 p.Research output: Contribution to journal › Review article › peer-review
183 Scopus citations -
2000
Transforming growth factor-β and breast cancer: Tumor promoting effects of transforming growth factor-β
Dumont, N. & Arteaga, C. L., 2000, In: Breast Cancer Research. 2, 2, p. 125-132 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access139 Scopus citations -
1999
Foundations of molecular therapies in breast carcinoma.
Arteaga, C. L., Oct 1999, In: Journal of mammary gland biology and neoplasia. 4, 4, p. 333-335 3 p.Research output: Contribution to journal › Review article › peer-review
-
1997
Growth factors and cytokines in health and disease. Breast cancer
Arteaga, C. L., 1997, In: Growth Factors and Cytokines in Health and Disease. 3, C, p. 293-330 38 p.Research output: Contribution to journal › Review article › peer-review
-
1996
Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression.
Koli, K. M. & Arteaga, C. L., Oct 1996, In: Journal of mammary gland biology and neoplasia. 1, 4, p. 373-380 8 p.Research output: Contribution to journal › Review article › peer-review
27 Scopus citations -
1994
TGF beta regulation of cell proliferation.
Moses, H. L., Arteaga, C. L., Alexandrow, M. G., Dagnino, L., Kawabata, M., Pierce, D. F. & Serra, R., 1994, In: Princess Takamatsu symposia. 24, p. 250-263 14 p.Research output: Contribution to journal › Review article › peer-review
25 Scopus citations